| Patient | Satchel Paige |
|---|---|
| Date of birth | 1953-07-07 |
| Identifiers | MRN HR-ML047-SYN; SSN (made up) 000-47-3381 |
| Document date | 2026-09-22 |
| Author | Delphine Whitaker-Osei, MD |
| Custodian | St. Posthumous Health Center |
Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.
More breathless, with more and greener sputum, for three days after a cold. [S]
Mr. Paige called the clinic this morning, as his action plan says to when his symptoms worsen, and was seen the same day. A cold went around his church two weeks ago; five days ago he had a runny nose and sore throat, and for three days he has been more breathless than usual, now after half a block, with more sputum that has turned from clear to green and wheeze at night. He has used his albuterol four to five times a day, which helps for a few hours. He has taken his umeclidinium-vilanterol every morning. His home temperature was 37.8 °C last night. He has no chest pain, no blood in the sputum, no leg swelling and no new orthopnea. He is not smoking. He missed his two rehabilitation sessions this week. A home rapid test for COVID-19 and influenza was negative yesterday. [S]
| Element | Detail |
|---|---|
| Onset | Three days ago, two days after a cold began |
| Severity | Breathless after half a block (worse than his usual one block); speaking in full sentences |
| Context | COPD on a LAMA with a LABA; no exacerbation in the past year |
| Associated signs and symptoms | More sputum, now green; wheeze at night; temperature to 37.8 °C; no chest pain, hemoptysis or leg swelling |
| Modifying factors | Albuterol helps for a few hours |
| System | Result | Finding |
|---|---|---|
| Constitutional | Positive | Low-grade temperature; tired; no rigors |
| Ears, nose, mouth, and throat | Positive | Runny nose and sore throat, settling |
| Respiratory | Positive | More breathlessness, more and green sputum, night wheeze; no hemoptysis |
| Cardiovascular | Negative | No chest pain, palpitations, orthopnea or ankle swelling |
4 systems reviewed. [S]
| Medication | Frequency | Route | Dates | Status | Evidence |
|---|---|---|---|---|---|
| Albuterol 90 micrograms per inhalation metered-dose inhaler with a spacer, two inhalations every four hours as needed for breathlessness | Two inhalations with a spacer every 4 hours as needed | Respiratory tract route | 2026-07-14 | active | S |
| Umeclidinium 62.5 micrograms with vilanterol 25 micrograms dry powder inhaler (a LAMA with a LABA), one inhalation once a day | One inhalation each morning; a strong, deep breath in | Respiratory tract route | 2026-07-28 | active | S |
| Atorvastatin 20 mg tablet once a day | One tablet each evening | Oral route | 2026-07-14 | active | S |
| Prednisone 40 mg (two 20 mg tablets) by mouth each morning for five days | Two tablets each morning with food for five days | Oral route | 2026-09-22 to 2026-09-26 | completed | S |
| Doxycycline 100 mg capsule by mouth twice a day for five days | One capsule twice a day with a full glass of water, sitting up, for five days | Oral route | 2026-09-22 to 2026-09-26 | completed | S |
| Allergy | Reaction | Status | Evidence |
|---|---|---|---|
| No known allergy | active | S |
| Date | Measure | Value | Unit | Provenance |
|---|---|---|---|---|
| 2026-09-22 | Body height | 191 | cm | S |
| 2026-09-22 | Body weight | 82.2 | kg | S |
| 2026-09-22 | Body mass index (BMI) [Ratio] | 22.5 | kg/m2 | S |
| 2026-09-22 | Systolic blood pressure | 134 | mm[Hg] | S |
| 2026-09-22 | Diastolic blood pressure | 80 | mm[Hg] | S |
| 2026-09-22 | Heart rate | 96 | /min | S |
| 2026-09-22 | Respiratory rate | 22 | /min | S |
| 2026-09-22 | Body temperature | 37.5 | Cel | S |
| 2026-09-22 | Oxygen saturation in Arterial blood by Pulse oximetry | 92 | % | S |
Vital signs recorded on 2026-09-22; see the Vital Signs section. [S]
| System | Finding |
|---|---|
| General | Mildly breathless at rest, speaking in full sentences; no use of accessory muscles; not confused |
| Vital signs | Temperature 37.5 °C; pulse 96; respiratory rate 22; blood pressure 134/80; oxygen saturation 92 percent on room air, from his usual 94 to 95 |
| Respiratory | Prolonged expiration with scattered wheeze on both sides; no crackles or bronchial breathing; good air entry |
| Cardiovascular | Regular rhythm; no murmur; no raised jugular venous pressure; no leg edema |
| Ears, nose, mouth, and throat | Mildly red throat; no exudate |
| Problem | Clinical status | Verification | Code | Provenance |
|---|---|---|---|---|
| Breathlessness on exertion for about two years, now after one flight of stairs or a block on the level (mMRC 2), with a morning cough and a little clear sputum most days; no chest pain, ankle swelling, orthopnea, wheeze at rest or weight loss; a former smoker of about 30 pack-years; cause under evaluation with spirometry and a pulmonology consultation | resolved | confirmed | R06.09 | S — Synthetic presenting problem anchored to his documented emphysema; superseded when spirometry at the consultation confirmed COPD. |
| Chronic obstructive pulmonary disease, GOLD grade 2 (post-bronchodilator FEV1/FVC 0.58, FEV1 61% predicted by the race-neutral GLI Global equations), GOLD group B (CAT 18, mMRC 2, no exacerbation in the past year); alpha-1 antitrypsin normal; blood eosinophils 0.08 x 10^3/uL; synthetic modern diagnosis linked to his documented emphysema | active | confirmed | J44.9 | S — Synthetic modern diagnosis made at the consultation, anchored to his documented emphysema; its onset and course in the modern episode are synthetic. |
| Former cigarette smoker, about 30 pack-years, stopped eleven years ago on his own; no use since | active | confirmed | Z87.891 | S — Synthetic smoking history: whether he smoked is not documented in the sources read, so the history is synthetic and labeled as such. |
| Hyperlipidemia: LDL 148 mg/dL, HDL 44 and triglycerides 160 at intake; estimated 10-year cardiovascular risk about 18 percent; atorvastatin started by shared decision | active | confirmed | E78.5 | S — Synthetic cardiovascular risk factor anchored to his documented heart trouble; not a claim about his real lipids. |
| Moderate exacerbation of COPD with a viral cold: more breathlessness, more sputum turning green, and wheeze for three days; oxygen saturation 92 percent; no pneumonia on chest X-ray; treated at home with prednisone and doxycycline; recovered | active | confirmed | J44.1 | S — Synthetic exacerbation at the sick visit; not a historical claim. |
Guideline basis: Global Strategy for the Prevention, Diagnosis and Management of COPD: 2025 Report (2025); Racial Bias in Pulse Oximetry Measurement (2020)
Follow-up: Review at the wellness visit in two weeks, or sooner as above. Next scheduled visit 2026-10-06: subsequent annual wellness visit. [S]